
Johannes Linxweiler
@jlinxweiler
Urologist at Saarland University Medical Center (Homburg/Saar)
ID: 919138543297093632
14-10-2017 09:51:20
31 Tweet
105 Followers
142 Following



Congratulations to chariskalogirou and Wolfgang Fendler for receiving the Alken Award 2019. #prostatecancer #PSMA



Robotic Salvage Lymph Node Dissection in Recurrent Prostate Cancer: Lessons Learned from 68 Cases and Implications for Future Clinical Management bit.ly/2RT3fyd Johannes Linxweiler


Identification of tumour specific markers on extracellular vesicles - successful isolation of EVs from different sources for development of specific markers. Another figure we recognise! Here's the paper by Johannes Linxweiler et al. rdcu.be/cQWxN






Join us at the Biozentrum, University of Basel in Basel for the #ESUR23 meeting to discuss the latest discoveries in #urologicalresearch! We will cover topics such as patient-derived #organoid and #mouse models, combination #therapies, #infectiology , #spatialbiology and #extracellularvesicles


Delighted for this highlighting by European Urology Niklas Klümper Alexander Cox OncoAlert More to come soon !!

Really grateful to have the opportunity presenting our work at #GU24 !! Genomic protein related biomarkers might be good correlated for precise smart targeted chemotherapies! ASCO UroToday.com OncoAlert Shilpa Gupta Enrique Grande Petros Grivas Viktor Grünwald

With a median FU up of ~5 yrs adjuvant pembro= 38% reduction in risk of death. The benefit is across subgroups (T stage etc). Subsequent therapy in 80% is relapses. The 1st +ve OS adjuvant PD1 study, making adjuvant pembro more attractive. #GU24 Toni Choueiri, MD


Nectin-4—drug conjugates (in metastatic urothelial carcinomas): The right drug for everyone? Happy to talk about current evidence to use Nectin-4 status to predict Enfortumab vedotin response in met. UC at #EAU24 in Paris European Association of Urology (EAU) ! Very interesting Session on saturday about




📣 Angesichts wachsender Einschränkungen der Forschungsfreiheit in den USA startet die Else Kröner-Fresenius-Stiftung ein neues Förderprogramm mit 10 Mio. €: Ziel ist es, exzellenten Medizinforschenden aus den USA langfristig eine Perspektive in Deutschland zu geben. ➡️ sohub.io/gcz8
